Scholars Central

Conference abstractPublished 14 Nov 2016

The underutilization of therapeutic hypothermia after cardiac arrest

Authors: Shawn W Blouin

University of South Florida, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Approximately 500,000 people every year experience a cardiac arrest, of whom less than 10% are resuscitated. Survivors often encounter neurologic sequelae ranging from moderate cognitive dysfunction to brain death. The only treatment known to protect the brain from injury after a cardiac arrest is therapeutic hypothermia. Mild hypothermia may decrease the area of injury, promote epicardial reflow, decrease myocardial metabolic demand, and preserve intracellular high-energy phosphate stores. A 2011 meta-analysis of randomized controlled trials found that therapeutic hypothermia with conventional cooling methods improves both survival and neurologic outcomes at hospital discharge for patients who experienced cardiac arrest. While the process of therapeutic hypothermia is cost efficient and relatively easy to provide, only about 13% of hospitals offer this treatment. The Hypothermia after Cardiac Arrest Study Group showed that, when applied to unconscious outof- hospital cardiac arrest patients with return of spontaneous circulation (n=274), mild hypothermia (cooling to 32-34Ã?ºC) provided significant improvement in functional recovery at hospital discharge (55% vs 39%; number needed to treat (NNT=6) and lower 6-month mortality rate when compared with patients who were not cooled (41% vs 55%) (NNT=7). Despite the inclusion of hypothermia in American Heart Association Guidelines for CPR and Emergency Cardiovascular Care in 2005, mild therapeutic hypothermia has lacked sufficient weight and is largely misunderstood and inconsistently applied. Barriers such as lack of equipment, education, and protocols have been attributed to its underutilization. Therefore, hospitals need to be proactively involved and create protocols to defend its underutilization to protect vital organs.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Shawn W Blouin”